The use of metformin as first line treatment in polycystic ovary syndrome

Irish Medical Journal

Volumn 101, Issue 2, 2008, Pages

  Abbas, M ^a   Gannon, M ^b  

^a Portiuncula Hospital   (Ireland)

^b Midland Regional Hospital Mullingar   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CLOMIFENE CITRATE; FOLLITROPIN; INSULIN; LUTEINIZING HORMONE; METFORMIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; TESTOSTERONE; ANTIDIABETIC AGENT; CLOMIFENE;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIET RESTRICTION; DRUG CHOICE; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; FEMALE; FEMALE INFERTILITY; GYNECOLOGY; HIRSUTISM; HUMAN; LABORATORY TEST; MONOTHERAPY; OBSTETRICS; OLIGOMENORRHEA; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY; RETROSPECTIVE STUDY; BODY MASS; DRUG EFFECT; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AMENORRHEA; BODY MASS INDEX; CLOMIPHENE; FEMALE; FOLLICLE STIMULATING HORMONE; HIRSUTISM; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; METFORMIN; MIDDLE AGED; OLIGOMENORRHEA; OVULATION; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 45549095496     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Franks J, Adams H and Mason D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 1995;12:603-633.
2. Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001;52:401-41.
3. Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynaecol Endocrinol 1987,1:235-245.
4. Franks S, Gilling-Smith C, Watson H. et al. (1999) Insulin action in the normal and polycystic ovary. Endocrinol. Metab. Clin. North Am, 28,361-378.
5. Kelly L and Adashi Y. Ovulation Induction. Obstet Gynecol Clin North Amer 1987;14:831-836.
6. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994;43:647-654.
7. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996;335:617-623.
8. Tarlatzis R, Fauser B, Chang J, Azziz R, Legro R et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Human Reproduction 2004:19;41-47.
9. Ciaraldi TP, El-roeiy A, Madar Z, Reichart D, Olefsky JM and Yen SC. (1992) Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab, 75,577-583.
10. Giannarelli R, Aragona M, Coppelli A, Del Prato S. Reducing insulin resistance with metformin: the evidence today. Diabetes Metab. 2003;29:6S28-35.
11. Homburg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:773-88.
12. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;297:1024-1026.
13. McCarthy EA, Walker SP, McLachlan K, Boyle J, Permezel M. Metformin in obstetric and gynaecologic practice: a review. Obstet Gynecol Surv 2004;59:118-127.
14. Carrington B, Sacks G, Regan L. Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 2005;17:591-597.
15. Brock B, Smidt K, Ovesen P, Schmitz O, Rungby J. Is metformin therapy for polycystic ovary syndrome safe during pregnancy? Basic Clin Pharmacol Toxicol 2005;96:410-2.
16. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001;75:46-52.
17. Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, doubleblind multicentre study. Hum Reprod 2006;21:80-89.
18. Levri KM, Slaymaker E, Last A, Yeh J, Ference J, D'Amico F, Wilson SA. Metformin as treatment for overweight and obese adults: a systematic review. Ann Fam Med 2005; 3:457-61.